|
CROT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51459999986336E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.29380000002399E-06 |
| Normal-vs-Stage2 |
5.183300E-03 |
| Normal-vs-Stage3 |
7.00279999543696E-08 |
| Normal-vs-Stage4 |
8.84660000033399E-07 |
| Stage1-vs-Stage2 |
9.571400E-01 |
| Stage1-vs-Stage3 |
2.244400E-02 |
| Stage1-vs-Stage4 |
4.857700E-02 |
| Stage2-vs-Stage3 |
1.149560E-01 |
| Stage2-vs-Stage4 |
1.739770E-01 |
| Stage3-vs-Stage4 |
8.711000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.94520000107445E-08 |
| Normal-vs-AfricanAmerican |
5.762500E-03 |
| Normal-vs-Asian |
5.151400E-01 |
| Caucasian-vs-AfricanAmerican |
2.191800E-01 |
| Caucasian-vs-Asian |
1.757830E-01 |
| AfricanAmerican-vs-Asian |
4.973200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04969999861859E-08 |
| Normal-vs-Female |
6.480400E-03 |
| Male-vs-Female |
4.243600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.59999999996374E-06 |
| Normal-vs-Extreme_Weight |
3.89419999580198E-08 |
| Normal-vs-Obese |
1.76679999996932E-06 |
| Normal-vs-Extreme_Obese |
5.514200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.467600E-01 |
| Normal_Weight-vs-Obese |
7.403200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.228200E-01 |
| Extreme_Weight-vs-Obese |
4.727600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.681800E-01 |
| Obese-vs-Extreme_Obese |
4.796400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.156500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.80599999999309E-06 |
| Normal-vs-Age(61-80Yrs) |
1.62820000004782E-06 |
| Normal-vs-Age(81-100Yrs) |
1.240010E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.431000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.706800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.054630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.772800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.261220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.467200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.66259999998275E-06 |
| Normal-VS-Type2 PRCC |
7.32980010020867E-10 |
| Normal-VS-KIRP CIMP |
1.475910E-03 |
| Normal-VS-Unclassified PRCC |
1.583170E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.995300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.189200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.681000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.979400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.465600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.077600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.77910003080251E-09 |
| Normal-vs-N1 |
1.3500000006772E-08 |
| Normal-vs-N2 |
5.664500E-03 |
| N0-vs-N1 |
5.110400E-01 |
| N0-vs-N2 |
7.865600E-01 |
| N1-vs-N2 |
5.553200E-01 |
|
|
